Groundbreaking studies indicate Semaglutide and Tirzepatide may reduce alcohol consumption in individuals with obesity

The impact of semaglutide and tirzepatide and glucagon-like peptide-1 receptor agonist medications on alcohol consumption.

New study may shed light on how parasite strain diversity can impact Chagas disease progression

New research from Tulane University may shed light on how parasite strain diversity can impact Chagas disease progression and severity.

September 5, 2023

Updated: In turnaround, ALX Oncology’s CD47 blocker shows efficacy in gastric cancer trial

Don’t write off CD47 just yet. ALX Oncology said that 52% of gastric cancer patients who received its anti-CD47 drug evorpacept in combination with a

October 4, 2023

Opinion | I’m an Autistic Doctor. Here’s How to Improve Care for Autistic Patients.

Pineo is a hospitalist and hospital medical director. In 1983, I signed up for a paper route at the age of 13. Every morning, I

April 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.